Literature DB >> 16964384

Effect of sulforaphane on cell growth, G(0)/G(1) phase cell progression and apoptosis in human bladder cancer T24 cells.

Yujuan Shan1, Changhao Sun, Xiujuan Zhao, Kun Wu, Aedin Cassidy, Yongping Bao.   

Abstract

Isothiocyanates (ITCs) from cruciferous vegetables have been shown to be effective in blocking initiation as well as progression of a range of chemically-induced tumors in animal models. In this study, sulforaphane, the most extensively studied ITC, was found to suppress the growth of T24 bladder cancer cells in vitro in a dose-dependent manner. Sulforaphane inhibited the proliferation of T24 cells with IC(5)0 values 26.9 and 15.9 microM following 24 and 48 h treatments. Sulforaphane (5-20 microM) induced early apoptosis and blocked cell cycle progression at G(0)/G(1) phase which was associated with upregulation of cyclin-dependent kinase inhibitor p27 expression. These results support a role for sulforaphane as an effective agent in the chemoprevention of bladder cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16964384

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  16 in total

1.  Cruciferous vegetables, isothiocyanates, and prevention of bladder cancer.

Authors:  Omkara L Veeranki; Arup Bhattacharya; Li Tang; James R Marshall; Yuesheng Zhang
Journal:  Curr Pharmacol Rep       Date:  2015-08

2.  Sulforaphane as a Promising Natural Molecule for Cancer Prevention and Treatment.

Authors:  Osama A Elkashty; Simon D Tran
Journal:  Curr Med Sci       Date:  2021-04-20

3.  The impact of cruciferous vegetable isothiocyanates on histone acetylation and histone phosphorylation in bladder cancer.

Authors:  Besma Abbaoui; Kelly H Telu; Christopher R Lucas; Jennifer M Thomas-Ahner; Steven J Schwartz; Steven K Clinton; Michael A Freitas; Amir Mortazavi
Journal:  J Proteomics       Date:  2017-01-27       Impact factor: 4.044

4.  Anticancer activity of a broccoli derivative, sulforaphane, in barrett adenocarcinoma: potential use in chemoprevention and as adjuvant in chemotherapy.

Authors:  Aamer Qazi; Jagannath Pal; Ma'in Maitah; Mariateresa Fulciniti; Dheeraj Pelluru; Puru Nanjappa; Saem Lee; Ramesh B Batchu; Madhu Prasad; Christopher S Bryant; Samiyah Rajput; Sergei Gryaznov; David G Beer; Donald W Weaver; Nikhil C Munshi; Raj K Goyal; Masood A Shammas
Journal:  Transl Oncol       Date:  2010-12-01       Impact factor: 4.243

5.  In Vitro-In Vivo Dose Response of Ursolic Acid, Sulforaphane, PEITC, and Curcumin in Cancer Prevention.

Authors:  Christina N Ramirez; Wenji Li; Chengyue Zhang; Renyi Wu; Shan Su; Chao Wang; Linbo Gao; Ran Yin; Ah-Ng Kong
Journal:  AAPS J       Date:  2017-12-20       Impact factor: 4.009

6.  Inhibition of bladder cancer by broccoli isothiocyanates sulforaphane and erucin: characterization, metabolism, and interconversion.

Authors:  Besma Abbaoui; Kenneth M Riedl; Robin A Ralston; Jennifer M Thomas-Ahner; Steven J Schwartz; Steven K Clinton; Amir Mortazavi
Journal:  Mol Nutr Food Res       Date:  2012-10-05       Impact factor: 5.914

Review 7.  [Primary prevention of bladder cancer. What's new?].

Authors:  J E Altwein
Journal:  Urologe A       Date:  2007-06       Impact factor: 0.639

Review 8.  Molecular targets of isothiocyanates in cancer: recent advances.

Authors:  Parul Gupta; Bonglee Kim; Sung-Hoon Kim; Sanjay K Srivastava
Journal:  Mol Nutr Food Res       Date:  2014-02-10       Impact factor: 5.914

9.  Simultaneous Targeting of Bladder Tumor Growth, Survival, and Epithelial-to-Mesenchymal Transition with a Novel Therapeutic Combination of Acetazolamide (AZ) and Sulforaphane (SFN).

Authors:  S S Islam; R B Mokhtari; P Akbari; J Hatina; H Yeger; W A Farhat
Journal:  Target Oncol       Date:  2016-04       Impact factor: 4.493

10.  Correction to: In Vitro-In Vivo Dose Response of Ursolic Acid, Sulforaphane, PEITC, and Curcumin in Cancer Prevention.

Authors:  Christina N Ramirez; Wenji Li; Chengyue Zhang; Renyi Wu; Shan Su; Chao Wang; Linbo Gao; Ran Yin; Ah-Ng Tony Kong
Journal:  AAPS J       Date:  2018-02-06       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.